Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin

In response to injury of the central nervous system, astrocytes become reactive and express high levels of the intermediate filament (IF) proteins glial fibrillary acidic protein (GFAP), vimentin, and nestin. We have shown that astrocytes in mice deficient for both GFAP and vimentin (GFAP-/-vim-/-)...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 145; no. 3; pp. 503 - 514
Main Authors Pekny, Milos, Johansson, Clas B., Eliasson, Camilla, Stakeberg, Josefina, Wallén, Åsa, Perlmann, Thomas, Lendahl, Urban, Betsholtz, Christer, Berthold, Claes-Henric, Frisén, Jonas
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 03.05.1999
The Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:In response to injury of the central nervous system, astrocytes become reactive and express high levels of the intermediate filament (IF) proteins glial fibrillary acidic protein (GFAP), vimentin, and nestin. We have shown that astrocytes in mice deficient for both GFAP and vimentin (GFAP-/-vim-/-) cannot form IFs even when nestin is expressed and are thus devoid of IFs in their reactive state. Here, we have studied the reaction to injury in the central nervous system in GFAP-/-, vimentin-/-, or GFAP-/-vim-/- mice. Glial scar formation appeared normal after spinal cord or brain lesions in GFAP-/- or vimentin-/- mice, but was impaired in GFAP-/-vim-/- mice that developed less dense scars frequently accompanied by bleeding. These results show that GFAP and vimentin are required for proper glial scar formation in the injured central nervous system and that some degree of functional overlap exists between these IF proteins.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Address correspondence to Dr. Milos Pekny, Department of Medical Biochemistry, University of Gothenburg, Box 440, SE-405 30 Gothenburg, Sweden. Tel.: 46 31 7733269. Fax: 46 31 416108. E-mail: milos.pekny @medkem.gu.se
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.145.3.503